Search
JD Health Shares Surge Over 3% in Morning Trading, Goldman Sachs Boosts Target Price to HK$42.50
2025-05-20 /
Read about 0 minute
Author：小编
In morning trading, JD Health's share price witnessed a notable surge of 3.30%, closing at HK$40.65. Goldman Sachs released a report highlighting that JD Health's first-quarter revenue and profit exceeded market expectations, primarily fueled by robust growth in pharmaceuticals and nutritional products, along with an expansion in gross margin. The investment bank reaffirmed its confidence in JD Health's leading market position. Despite the management's relatively cautious guidance for the current year, Goldman Sachs opted to increase its average revenue forecast for JD Health from 2023 to 2027 by 2%, elevate its net profit forecast by 1%-3%, and elevate the target price from HK$37.8 to HK$42.50, maintaining a "Buy" rating.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
